Series date: 
01/05/2023 - 12:15pm MST to 12/28/2023 - 1:15pm MST

These courses are intended for internal hospital staff.

Activity Description:

Hematology Radiology series focuses on appropriate treatments option for patients and review new advances in the most current therapeutic approach for common oncology cases. Identify appropriate procedures and treatments to communicate with other professionals involved. Multidisciplinary approach to patient care by evaluating all available treatment options to obtain appropriate treatment modalities. Each series content focuses on diagnosis, treatment and management of cancer patients of all ages and all states of disease while improving the quality and safety of cancer diagnosis and treatment.

Target Audience:

Specialties - Infectious Disease, Pulmonary, BMT & Radiology, Physician Assistants, Nurses

Learning Objective:

At the conclusion of this course, learners should be able to:

  • Multidisciplinary approach to patient care by evaluating all treatment options
  • Identify new advances in current therapeutic approach for oncology cases
  • Improve patient care through knowledge

 

Moderator:

Richard Nash, MD

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose. 

Series location: 
Presbyterian St. Luke's Medical Center
1719 E 19th Ave
Denver, CO 80218
United States